National University Hospital (Singapore)
The National University Hospital (NUH) is a tertiary hospital and major referral centre for a comprehensive range of medical, surgical and dental specialties. The Hospital also provides organ transplant programmes for adults (in kidney, liver and pancreas) and is the only public hospital in Singapore to offer a paediatric kidney and liver transplant programme.
Staffed by a team of healthcare professionals who rank among the best in the field, the NUH offers quality patient care by embracing innovations and advances in medical treatment.
In 2004, the NUH became the first Singapore hospital to receive the Joint Commission International (JCI) accreditation, an international stamp for excellent clinical practices in patient care and safety. Today, patient safety and good clinical outcomes remain the focus of the hospital as it continues to play a key role in the training of doctors, nurses and allied health professionals, and in translational research which paves the way for new cures and treatment, offering patients hope and a new lease of life.
A member of the National University Health System, it is the principal teaching hospital of the NUS Yong Loo Lin School of Medicine and the NUS Faculty of Dentistry.
Equipped with state-of-the-art facilities and experienced staff, NUH is a major referral centre that provides advanced medical care for a comprehensive range of medical, surgical and dental conditions. These include Cardiology, Gastroenterology & Hepatology, Obstetrics & Gynaecology, Ophthalmology, Oncology, Paediatrics, Orthopaedic Surgery, and Hand and Reconstructive Microsurgery.
The Hospital also offers organ transplant programmes for adults (kidney, liver and pancreas) and is the only public hospital in Singapore to offer a paediatric kidney and liver transplant programme.
A key member of the National University Health System, Singapore’s first Academic Health System, NUH hosts some of the best and brightest clinical and scientific brains. Our clinicians and scientists work hand-in-glove to achieve major advances in patient care, in areas ranging from cancer to heart diseases, to neurological illnesses and infectious diseases. Thriving research findings translate to new drugs, devices and treatments benefiting our patients.
Providing better, more efficient care
As patients today are increasingly seen with multiple co-morbidities, well-coordinated and integrated care is needed and will ensure they are treated in the most appropriate environment.
At the National University Cancer Institute, Singapore (NCIS) and the National University Heart Centre Singapore (NUHCS) – both conveniently housed within the NUH premises – dedicated cancer and heart care are provided to better support the growing complexities of public healthcare needs in Singapore.
Initiatives to transfer selected inpatient treatments and surgeries to the outpatient setting have also benefited patients by reducing hospitalisation costs and treatment time for them. For example, the Outpatient Procedure Centre and OPAT(Outpatient Parental Antibiotic Therapy) facility allow patients with specific conditions and infections to be treated via intravenous infusions, without having to be hospitalised. Similarly, the Dengue Outpatient Management (DOM) Clinic helps assess and monitor the conditions of dengue patients who no longer need to be admitted into the hospital.
Hope for patients with Type 1 diabetes
Led by the National University Centre for Organ Transplantation team, the nation’s first simultaneous pancreas-kidney (SPK) transplant was successfully carried out in 2012. The landmark surgery spells new hope for patients who suffer from diabetes and kidney failure. A successful SPK transplant increases the five-year survival rate to more than 90% (35% if without a transplant). More importantly, patients enjoy better quality of life, free from dialysis.
Nabbing diabetic kidney disease early
The Nephrology Evaluation, Management and Optimisation (NEMO) programme was set up in 2011 by NUH and the National Healthcare Group Polyclinics (NHGP) to help patients with early-stage diabetic kidney disease (DKD) reduce their risk of progressing to more advanced stages of the disease. Apart from being diagnosed and treated early, patients under the programme are also closely monitored and guided on managing their condition more effectively. Since its inception, Project NEMO has helped more patients reduce their risk of progressive DKD through drug optimisation.
Removing stomach tumours without incisions
In 2011, our gastroenterologist took the technique a step further with the Master and Slave Transluminal Endoscopic Robot (MASTER), where patients with stomach cancer can have their tumours removed via the mouth without a single incision or scar. While it is currently designed for the removal of tumours, developments of interchangeable effectors will allow MASTER to be used in other surgeries.
Improving patient care and safety with technology
In 2014, NUH became the first local hospital to introduce the macerator, a human waste disposal system that uses single-use bedpans, urinals and vomit bowls instead of reusable ones. The new system helps prevent odours and reduces the spread of infections. It also halves the time nurses need for cleaning duties and allows them to focus on patient care
Reversing brittle bone disease in the womb
A team of experts from the Obstetrics & Gynaecology and Paediatrics departments was part of an international collaboration to treat two babies with Osteogeneis Imperfecta (OI) or brittle bone disease, by infusing bone forming stem cells through the womb. The NUH team had carried out the first infusion on one of the children, a baby girl from Taiwan, in 2009. She was given a second dose the following year at age one. With both children doing well today, this research finding spells hope for unborn babies with brittle bone disease.
Less is more for children with cancer
Thanks to a new chemotherapy treatment protocol, children with acute lymphoblastic leukaemia (ALL) are now spared serious complications such as organ damage. Their cure rate and quality of life are improved. The multi-centre study in Singapore and Malaysia, led by the NUH Department of Paediatrics, found that 86% of the patients can be given a significantly lower dose of chemotherapy without affecting their long-term cure rate, also reducing treatment costs for the patients and their families. Today, our overall survival rate for childhood ALL stands at 91 per cent, which is comparable to the 94 per cent ALL survival rate at the world-renowned St Jude’s Children’s Research Hospital.
Heart Disease Treatment
The Heart Centre of the National University of Singapore has combined the resources, experience and capabilities of cardiology, cardiosurgery and vascular surgery to better meet the needs of the growing number of patients with cardiovascular diseases. The Centre provides treatment and maintaining of patients with such complex diseases as: acute coronary syndrome, heart failure, congenital heart disease, and other vascular diseases.
The team, composed of experts and specialists in various therapeutic and surgical disciplines, provides a comprehensive and holistic approach to the treatment of patients with heart diseases. This approach is supported by knowledge and information gathered by the Heart-Vascular Research Institute. Working in close collaboration with local and international renowned scientific institutions such as Agency for Science, Technology and Research (A'star) in Singapore and Christchurch School of Medicine and Health Sciences in New Zealand, Heart Centre focuses on the development of a niche for research work in various clinical programmes: myocardial infarction, heart failure, congenital and vascular heart diseases and others.
The Cancer Institute of the National University of Singapore offers a wide range of treatments for cancer, both for adults and children. The Institute carries out prevention, early diagnosis, clinical diagnosis, treatment, rehabilitation and palliative care.
The advantage of Cancer Centre is the multidisciplinary approach, which allows the development of a comprehensive and individual treatment plan for each patient. Specialists such as onco-therapists, onco-surgeons, hematologists, radiotherapists, paediatricians, onco-gynaecologists, pathology, gastroenterologists, hepatologists, infectiologists, pulmonologists, emergency physicians, pharmacists, psychotherapists, etc. are actively involved in the treatment process.
Cancer Center has opened Oncology and Genetics Centre, where prevention, general examination and identification of patients with a genetic predisposition to oncology diseases are carried out. Early diagnosis of oncology diseases is also carried out, allowing to begin treatment at a very early stage of the disease. All of these activities are aimed at reducing the mortality rate from oncology diseases. Many awards and prizes received by the scientific staff of the Institute brought its international fame and impeccable reputation. Close cooperation with the Scientific Cancer Centre of Singapore and the use of the latest research in the tteatment process has enabled our patients to have access to the latest diagnostic and treatment techniques.MEDICAL CENTRES INCLUDED IN THE HOSPITAL:
Pediatrics and Children's Surgery
Diabetes Treatment Centre
The National University Hospital strives to achieve the highest quality standards in the provision of health services. National University Hospital continually uses the latest treatment methods, improves treatment procedures, and has succeeded in treating diseases such as: cataracts, children's leukemia, stomach cancer (operation for full resect stomach in malignant neoplasm) and nasopharynx cancer. Complex operations such as heart surgery, liver transplant, and other operations are also successfully carried out here.
* All information on the site is a reference.